Genomics and Pharmaceutical Industry-Industryexperts-converted
                     Genomics and Pharmaceutical Industry – a vital partnership  
for treatment and control of diseases.
Genomics, the study of genes, is considered to be the most transformative  
technology of the 21st century. Genomics has scientifically proven abilities in the  
prevention, management and treatment of diseases and has emerged as a useful  
and effective way to diagnose serious diseases like cancer, ancestry genetic  
diseases, etc., For example, genome sequencing helps in detecting the cancer in  
its early stage and helps the clinicians to provide proper oncology treatments for  
patients.
COVID-19 has positively impacted the genomics market as the researchers have  
gained a better understanding of the coronavirus because of the innovative  
genome technologies with senior scientists and researchers confirming that  
genome sequencing has revealed that the omicron variant shows a lot of mutation  
in its spike protein, unlike the delta variant.
Advanced genomics techniques have made the process of sequencing a lot easier  
and today, a human genome can be sequenced within 24 hours and consumers  
can purchase a DNA sequence that can reveal their ethnic lineage going back  
generations.
Valued at USD 20.1 billion in 2020 the global market of the genomics industry  
was expected to grow at a CAGR of 15.35% from 2021 to 2028. The top global  
genomics company like Illumina, Genomic Health, Bluebird Bio, CRSPR  
Therapeutics have helped in expanding the availability, accessibility and quality  
of genomic-based health services. It is expected that the next few years will reveal  
more human genomic information which will help in enabling new therapeutic  
and preventive options to treat human diseases.
Talking about the Indian genomics industry, the India oncology next-generation  
sequencing (NGS) market size was valued at USD 16.87 million in 2020 and is
expected to grow at a CAGR of 19.6% from 2021 to 2028. Medgenome, Redcliffe  
life sciences, Lilac Insights, The Gene Lab are the top Indian gene testing  
companies which are using properly advanced technologies and are continuously  
working towards the improvement of patient care and disease management.
Initiatives taken by the government to build a genomic database for the Indian  
population and an exponential decline in the costs of genetic sequencing has  
driven the market growth and according to the professionals, India holds great  
potential in genomics as the market is continuously rising. The Genome India  
Project, initiated by the department of Biotechnology in 2020, intended to collect  
10,000 samples of Indian citizens to build reference genome. Very recently, the  
Government of India has identified genomics as a thrust sector and have  
announced several schemes with participatory funding from the Government.
Such initiatives are expected to increase the usage of genomic products, which  
will drive the growth of the Indian Genomics industry.
The essential genetic developments and their applications in various areas like  
bioengineering, synthetic biology, epistasis, intragenomic phenomena etc. have  
resulted in the massive growth of the genomics market. The participation of the  
pharmaceutical industry in such research shall result in the development of  
advanced drugs and medicines and thereby contract manufacture. India is known  
as the Pharmacy of the World and thus stands in a unique position for contract  
manufacture. The contract manufacture under license of the Astrazeneca and  
other vaccines for Covid 19 for both domestic consumption and vital exports  
including supplies to the WHO, is a case in point with regard to
contract pharmaceutical manufacturers in India.